Discriminative accuracy of BD‐tau and clinical variables for predicting unfavorable functional outcome in the combined Sahlgrenska Academy Study on Ischemic Stroke (SAHLSIS) and SAHLSIS phase 2 (SAHLSIS2) cohort using receiver operating characteristic (ROC) curve analysis. The gene discussed is MAPT; the disease is ischemic stroke.